AndreaBozzo/ceres-open-data-index huggingface dataset:
NNDSS - Table II. Spotted Fever Rickettsiosis to Syphilis

NNDSS - Table II. Spotted Fever Rickettsiosis to Syphilis - 2016.  In this Table, provisional* cases of selected† notifiable diseases (≥1,000 cases reported during the preceding year), and selected low frequency diseases are displayed. The Table includes total number of cases reported in the United States, by region and by states, in accordance with the current method of displaying MMWR data.  Data on United States exclude counts from US territories.
Note:
These are provisional cases of selected national notifiable diseases, from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data reported by the 50 states, New York City, the District of Columbia, and the U.S. territories are collated and published weekly as numbered tables printed in the back of the Morbidity and Mortality Weekly Report (MMWR). Cases reported by state health departments to CDC for weekly publication are provisional because of ongoing revision of information and delayed reporting. 

Case counts in this table are presented as they were published in the MMWR issues. Therefore, numbers listed in later MMWR weeks may reflect changes made to these counts as additional information becomes available. 

Footnotes:
C.N.M.I.: Commonwealth of Northern Mariana Islands. 
U: Unavailable.    -: No reported cases.    N: Not reportable.    NN: Not Nationally Notifiable.   NP:  Nationally notifiable but not published.  Cum: Cumulative year-to-date counts.    Med: Median.    Max: Maximum.

* Case counts for reporting year 2016 are provisional and subject to change.   For further information on interpretation of these data, see http://wwwn.cdc.gov/nndss/document/ ProvisionalNationaNotifiableDiseasesSurveillanceData20100927.pdf. Data for TB are displayed in Table IV, which appears quarterly.
† Three low incidence conditions, rubella, rubella congenital, and tetanus, have been moved to Table II to facilitate case count verification with reporting jurisdictions.
§ Illnesses with similar clinical presentation that result from Spotted fever group rickettsia infections are reported as Spotted fever rickettsioses.   Rocky Mountain spotted fever (RMSF) caused by Rickettsia rickettsii, is the most common and well-known spotted fever.
Compound 526608: 1,3-Di-O-acetyl-2,6-anhydro-4,5-di-O-methylhexitol

Chemical compound data from PubChem database. IUPAC Name: (3-acetyloxy-4,5-dimethoxyoxan-2-yl)methyl acetate. Molecular Formula: C12H20O7. Molecular Weight: 276.28. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Elk Creek Seismic Waveforms 2011 (Part 5 of 19)

Coal bursts (damaging seismic events in underground coal mines) pose a substantial threat to operations and mine workers. The underground coal mines in Colorado’s North Fork Valley (NFV) have experienced many coal bursts, often with distinct characteristics from those of other US coal mining regions. To better understand these events and manage their associated risks, the National Institute for Occupational Safety and Health undertook a long-term monitoring campaign at the Elk Creek Mine in the NFV. The monitoring efforts included a seismic network composed of both surface and underground sensors, borehole pressure cells (BPCs), instrumented support Cans, convergence monitors, ground condition surveys, and several other data sources. This dataset consists of the event waveform files from the seismic network for the 983,379 events that were detected during the monitoring campaign. The waveforms are stored in HDF5 files that are broken up by week. Within the HDF5 files, the data are organized by station id, event time, and channel. The amplitudes are velocity in meters/second.
 
This is download 13 of 48 and corresponds to the time range between January 31, 2011, and February 7, 2011.
Levocetirizine dihydrochloride

Levocetirizine Dihydrochloride is an over-the-counter antihistamine that helps relieve allergy symptoms like runny nose, sneezing, itchy eyes, and hives. Available as 5 mg coated tablets taken orally, it's marketed by Dr. Reddy's Laboratories and Walmart. This information was generated using AI and is provided for informational and research purposes only.
Phylogenetic analysis of 277 human G-protein-coupled receptors as a tool for the prediction of orphan receptor ligands

G-protein-coupled receptors (GPCRs) are the largest and most diverse family of transmembrane receptors. A pylogenetic analysis shows the overall relationship of 277 human GPCRs. An emphasis on receptors with no identified natural ligand may prove valuable for identification of the ligands of 'orphan' receptors.
2014 CMHS Uniform Reporting System (URS) Table for Hawaii

2014 Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Output Tables for Hawaii. The URS state reporting system is collected annually to support the Community Mental Health Services Block Grant program. State Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization measures providing an overview of state mental health delivery systems.
Compound 527376: 20,24-Dimethyl-triacontyl cyanide

Chemical compound data from PubChem database. IUPAC Name: 21,25-dimethylhentriacontanenitrile. Molecular Formula: C33H65N. Molecular Weight: 475.9. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 525851: N,N-Dimethyl-2-phenyl-N'-(3-methylphenyl)-acetamidine

Chemical compound data from PubChem database. IUPAC Name: N,N-dimethyl-N'-(3-methylphenyl)-2-phenylethanimidamide. Molecular Formula: C17H20N2. Molecular Weight: 252.35. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E39968-T1: [Translated] PROCESS FOR THE MANUFACTURE OF SCAFFOLDING, ESPECIALLY LADDERS.

The invention relates to a method of producing scaffolds, especially ladders. In order to provide a construction solely made of an insulant material, the rails (5) and the rungs (1) of a ladder according to the invention are wholly made of reinforced plastic and are joined to each other by means of a polymeric cold junction method. Thereby a hole (18) is provided on the side of the rail (5) and a suitable amount of a mineral or fiber reinforced monomer mixture (2) is added therein, whereafter the rung (1) is positioned thereto and the resultant whole Is turned upside down, the monomer mixture being polymerized by means of heat, a catalyst and/or an accelerator. So the monomer mixture flows around the junction of the rung (1) and the rail (5), polymerizing therein and forming a tight joint between the rung and the rail.
Assessment of Filtration Efficiency, Manikin Fit Performance, and Strap Performance for Decontaminated N95 Filtering Facepiece Respirators

Supplies of N95® filtering facepiece respirators (FFRs) can become depleted during widespread outbreaks of infectious respiratory illnesses. To supplement the national inventory of NIOSH Approved® N95 FFRs during times of extreme shortages, FFR reuse following decontamination is a possible strategy. Decontamination is a process to reduce the number of pathogens on used FFRs before reuse. An effective FFR decontamination technique should significantly reduce the pathogen burden, but not reduce a respirator’s filtration performance or its ability to fit properly. Another consideration is that no hazardous chemical residue should be left on the FFR following the decontamination process.
Compound 526459: Pentyl perfluoropentanoate

Chemical compound data from PubChem database. IUPAC Name: pentyl 2,2,3,3,4,4,5,5,5-nonafluoropentanoate. Molecular Formula: C10H11F9O2. Molecular Weight: 334.18. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Influenza ICU Cases by Week and Demographic/Medical Category - Historical

NOTE: This dataset is no longer being updated but is being kept for historical reference. For current data on respiratory illness visits and respiratory laboratory testing data please see <a href="https://data.cityofchicago.org/Health-Human-Services/Influenza-COVID-19-RSV-and-Other-Respiratory-Virus/qgdz-d5m4">Influenza, COVID-19, RSV, and Other Respiratory Virus Laboratory Surveillance</a> and <a href="https://data.cityofchicago.org/en/Health-Human-Services/Inpatient-Emergency-Department-and-Outpatient-Visi/7ce8-bpr6">Inpatient, Emergency Department, and Outpatient Visits for Respiratory Illnesses</a>. 

In Illinois, influenza associated Intensive Care Unit (ICU) hospitalizations are reportable as soon as possible, but within 24 hours. Influenza associated ICU hospitalizations are defined as individuals hospitalized in an ICU with a positive laboratory test for influenza A or B, including specimens identified as influenza A/H3N2, A/H1N1pdm09, and specimens not subtyped (e.g., influenza positive cases by PCR or any rapid test such as EIA).

This dataset represents weekly aggregated information for influenza-associated ICU hospitalizations among Chicago residents, which is a reportable condition in Illinois.  

Information includes demographics, influenza laboratory results, vaccination status, and death status.

Column names containing "REPORTED" indicate the number of cases for which the indicated data element was reported. This, rather than the total number of cases, is used to calculate the corresponding percentage.

All data are provisional and subject to change. Information is updated as additional details are received. At any given time, this dataset reflects data currently known to CDPH. Numbers in this dataset may differ from other public sources.
Clobetasol propionate

Clobetasol Propionate is a generic topical spray containing 0.05% of the active ingredient, a corticosteroid used to treat inflammatory skin conditions like psoriasis or eczema. Manufactured by Glenmark Pharmaceuticals Inc., USA, under ANDA209004, it was available in 59 mL and 125 mL bottles but is now discontinued. This information was generated using AI and is provided for informational and research purposes only.
Weekly Cumulative Estimated Number of RSV Vaccinations Administered in Retail Pharmacies and Physicians' Medical Offices, Adults 50 to 74 Years and 75 years and older, United States

• Weekly Cumulative Estimated Number of RSV Vaccinations Administered in Retail Pharmacies and Physicians’ Medical Offices, Adults 50–74 Years and 75 Years and Older, United States 

• In June 2023, the Advisory Committee on Immunization Practices (ACIP) voted to recommend that adults aged ≥60 years may receive a single dose of an RSV vaccine, using shared clinical decision-making. In June 2024, the ACIP voted to recommend a single dose of RSV vaccine for all adults 75 years and older and adults 60–74 years who are at increased risk for severe RSV disease.† On June 26, 2024, CDC adopted these recommendations. In April 2025, ACIP recommended that adults 50–59 years who are at increased risk for severe RSV disease were added to the previous recommendation. This recommendation was adopted by the HHS Secretary on June 25, 2025.  The data below capture the number of RSV doses administered to adults 50 years and older.† 

• The projected pharmacy estimates are based on IQVIA‡,§ Longitudinal Prescription Claims (LRx) (https://www.iqvia.com/insights/the-iqvia-institute/available-iqvia-data) and vaccinations administered in retail pharmacies (including chain, mass merchandise, food stores, and independent pharmacies). ± The projected physicians’ medical offices estimates are based on IQVIA’s Medical Claims (Dx) (https://www.iqvia.com/insights/the-iqvia-institute/available-iqvia-data).^  

• Vaccinations administered in workplaces, community locations, long-term care settings, and other medical settings such as public health clinics are not represented in these data.
Compound 528826: 1,2-Diethoxy-3-ethylbenzene

Chemical compound data from PubChem database. IUPAC Name: 1,2-diethoxy-3-ethylbenzene. Molecular Formula: C12H18O2. Molecular Weight: 194.27. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
MCM2 - a promising marker for premalignant lesions of the lung: a cohort study

Background
          Because cells progressing to cancer must proliferate, marker proteins specific to proliferating cells may permit detection of premalignant lesions. Here we compared the sensitivities of a classic proliferation marker, Ki-67, with a new proliferation marker, MCM2, in 41 bronchial biopsy specimens representing normal mucosa, metaplasia, dysplasia, and carcinoma in situ.
        
        
          Methods
          Parallel sections were stained with antibodies against MCM2 and Ki-67, and the frequencies of staining were independently measured by two investigators. Differences were evaluated statistically using the two-sided correlated samples t-test and Wilcoxon rank sum test.
        
        
          Results
          For each of the 41 specimens, the average frequency of staining by anti-MCM2 (39%) was significantly (p < 0.001) greater than by anti-Ki-67 (16%). In metaplastic lesions anti-MCM2 frequently detected cells near the epithelial surface, while anti-Ki-67 did not.
        
        
          Conclusions
          We conclude that MCM2 is detectable in 2-3 times more proliferating premalignant lung cells than is Ki-67. The promise of MCM2 as a sensitive marker for premalignant lung cells is enhanced by the fact that it is present in cells at the surface of metaplastic lung lesions, which are more likely to be exfoliated into sputum. Future studies will determine if use of anti-MCM2 makes possible sufficiently early detection to significantly enhance lung cancer survival rates.
Compound 526679: Methyl 3-[(trimethylsilyl)oxy]cholan-24-oate

Chemical compound data from PubChem database. IUPAC Name: methyl 4-(10,13-dimethyl-3-trimethylsilyloxy-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoate. Molecular Formula: C28H50O3Si. Molecular Weight: 462.8. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Child and Family Services Reviews Update: Volume 8, Issue 1, January 2016

This issue of Child and Family Services Reviews Update contains the following sections: 2015 State Reviews, 2016 and 2017 State Reviews, CFSR Procedures Manual: Updates, Onsite Review Instrument and Instructions: Updates, and JBS: CFSR Reviewers and QA/Note-Taking Specialists.

Metadata-only record linking to the original dataset. Open original dataset below.
Representation of women's health in general medical versus women's health specialty journals: a content analysis

Background
          Women's health, traditionally defined, emphasises reproductive and maternal conditions without consideration of social contexts. Advocates urge a broader conceptualisation. The medical literature influences the definitions and delivery of women's health care. We compared how women's health was represented in leading general medical (GM) versus women's health specialty (WS) journals.
        
        
          Methods
          Original investigations published between January 1 – June 30, 1999 in leading GM (n = 514) and WS (n = 82) journals were compared. Data were collected from 99 GM and 82 WS articles on women's health. Independent reviewers conducted content analyses of sample characteristics, study design, and health topic. Each article was classified as "Traditional" (e.g. menstruation, breast cancer), "Non-traditional" (e.g. abuse, osteoporosis), or "Both."
        
        
          Results
          Of the GM articles, 53 (53.5%) focused solely on a traditional women's health topic; half were reproductive and half female cancers. In contrast, 22 (26.8%) WS articles were traditionally focused. A non-traditional topic was the sole focus of 27 (27.3%) GM articles versus 34 (41.5%) WS articles. One-fifth of GM and one-third of WS articles addressed both. RCTs dominated the GM articles, while 40% of WS articles used qualitative or mixed study designs. Leading sources of women's death and disability were not well covered in either type of journal.
        
        
          Conclusions
          Most GM articles drew on a narrow definition of women's health. WS journals provided more balanced coverage, addressing social concerns in addition to "navel-to-knees" women's health. Since GM journals have wide impact, editorial decisions and peer review processes should promote a broader conceptualisation of women's health.
Compound 529119: 4-Quinazolone, 3-ethyl-2-pentyl

Chemical compound data from PubChem database. IUPAC Name: 3-ethyl-2-pentylquinazolin-4-one. Molecular Formula: C15H20N2O. Molecular Weight: 244.33. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Annotated Bibliography on Equity in Health, 1980-2001

The purposes of this bibliography are to present an overview of the published literature on equity in health and to summarize key articles relevant to the mission of the International Society for Equity in Health (ISEqH). The intent is to show the directions being taken in health equity research including theories, methods, and interventions to understand the genesis of inequities and their remediation. Therefore, the bibliography includes articles from the health equity literature that focus on mechanisms by which inequities in health arise and approaches to reducing them where and when they exist.
NSDUH 2017 Editing and Imputation Report

This report focuses on the editing and statistical imputation procedures that were applied to respondent data for the 2017 NSDUH. Logical editing uses data from elsewhere within the same respondent's record to reduce the occurrence of missing or ambiguous data or to resolve inconsistencies between related variables. Imputation is defined as the replacement of missing values with valid, nonmissing values. Statistical imputation usually involves some randomness to preserve the natural variability in the data.
Compound 526200: Methyl 4-methyl-2-[[2-(3-oxo-2-pent-2-enylcyclopentyl)acetyl]amino]pentanoate

Chemical compound data from PubChem database. IUPAC Name: methyl 4-methyl-2-[[2-(3-oxo-2-pent-2-enylcyclopentyl)acetyl]amino]pentanoate. Molecular Formula: C19H31NO4. Molecular Weight: 337.5. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
NNDSS - Table II. West Nile virus disease

NNDSS - Table II. West Nile virus disease - 2017.  In this Table, provisional cases of selected notifiable diseases (≥1,000 cases reported during the preceding year), and selected low frequency diseases are displayed.  The Table includes total number of cases reported in the United States, by region and by states, in accordance with the current method of displaying MMWR data.  Data on United States exclude counts from US territories.

Note:
These are provisional cases of selected national notifiable diseases, from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data reported by the 50 states, New York City, the District of Columbia, and the U.S. territories are collated and published weekly as numbered tables printed in the back of the Morbidity and Mortality Weekly Report (MMWR). Cases reported by state health departments to CDC for weekly publication are provisional because of ongoing revision of information and delayed reporting. 

Case counts in this table are presented as they were published in the MMWR issues. Therefore, numbers listed in later MMWR weeks may reflect changes made to these counts as additional information becomes available. 

Footnotes:
 C.N.M.I.: Commonwealth of Northern Mariana Islands. 

 U: Unavailable. —: No reported cases. N: Not reportable. NN: Not Nationally Notifiable. NP: Nationally notifiable but not published. Cum: Cumulative year-to-date counts. Med: Median. Max: Maximum. 

*Three low incidence conditions, rubella, rubella congenital, and tetanus, are in Table II to facilitate case count verification with reporting jurisdictions. 

† Case counts for reporting year 2017 are provisional and subject to change. For further information on interpretation of these data, see http://wwwn.cdc.gov/nndss/document/ ProvisionalNationaNotifiableDiseasesSurveillanceData20100927.pdf. Data for tuberculosis are displayed in Table IV, which appears quarterly.

§ Updated weekly from the Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases (ArboNET Surveillance). Data for Jamestown Canyon virus, La Crosse virus, Chikungunya virus, Eastern equine encephalitis virus, Powassan virus, St. Louis virus, and Western equine encephalitis virus diseases are available in Table I. 

¶ Not reportable in all states. Reporting exceptions are available at http://wwwn.cdc.gov/nndss/downloads.html.
2016-2018 Substate Estimates of Substance Use and Mental Illness

Substate estimates for 15 measures of substance use and mental illness based on the combined 2016, 2017, and 2018 National Surveys on Drug Use and Health (NSDUHs) are provided. NSDUH is an ongoing survey of the civilian, noninstitutionalized population of the United States aged 12 years or older. Estimates presented here are based on a small area estimation (SAE) methodology in which substate-level NSDUH data are combined with county and census block group/tract-level data from the state.
Weekly Differences in Cumulative RSV Vaccination Coverage Among Adults 75 and Older and 60-74 Years with High-Risk Conditions Ever Vaccinated with RSV Vaccine, Overall, by Selected Demographics

. Weekly Cumulative RSV Vaccination Coverage and Intent Among Adults 75 Years and Older and 60?74 Years with High Risk Conditions Ever Vaccinated with RSV Vaccine by Demographic Characteristics and Jurisdiction 
. Weekly estimates of RSV vaccination coverage and intent among adults 75 years and older and 60?74 years with high risk conditions are calculated using data from the National Immunization Survey-Adult COVID Module (NIS-ACM) (https://www.cdc.gov/nis/about/)
. In June 2023, the Advisory Committee on Immunization Practices (ACIP) voted to recommend that adults aged ?60 years may receive a single dose of an RSV vaccine, using shared clinical decision-making. In June 2024, the ACIP voted to recommend a single dose of RSV vaccine for all adults 75 years and older and adults 60-74 years who are at increased risk for severe RSV disease. The data below captures ever receiving a dose of an RSV vaccine by adults 60 years and older.?